Skip to search formSkip to main contentSkip to account menu

LY 518674

Known as: LY-518674, LY518674 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
AIMS Fibrate medications weakly stimulate the nuclear receptor peroxisome proliferator-activated receptor-α (PPAR-α) and are… 
Highly Cited
2009
Highly Cited
2009
2009
2009
Objective—The study of PPAR-α activation on apoA-I production in humans has been limited to fibrates, relatively weak PPAR… 
Highly Cited
2008
Highly Cited
2008
Fibric acid-shaped drugs raise high-density lipoprotein (HDL) cholesterol by upregulating the HDL-related genes through… 
Highly Cited
2007
Highly Cited
2007
CONTEXT Fibrates are weak agonists of peroxisome proliferator-activated receptor alpha (PPAR-alpha). No trials have reported… 
2005
2005
Low high-density lipoprotein-cholesterol (HDL-c) is an important risk factor of coronary artery disease (CAD). Optimum therapy… 
2005
2005
Low high-density lipoprotein-cholesterol (HDL-c) is an important risk factor of coronary artery disease (CAD). Optimum therapy… 
2003
2003
A new series of hPPARalpha agonists containing a 2,4-dihydro-3H-1,2,4-triazol-3-one (triazolone) core is described leading to the…